TBK1 and neoplasm: Due to the promoting effect of hepatic fibroinflammatory condition on the tumor immunosuppression (5), it is possible that the TBK1 antagonist attenuated the HCC immunosuppression by reducing the fibrosis and inflammatory environment of liver.